S.B. Vliek

487 total citations
7 papers, 59 citations indexed

About

S.B. Vliek is a scholar working on Oncology, Genetics and Economics and Econometrics. According to data from OpenAlex, S.B. Vliek has authored 7 papers receiving a total of 59 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Genetics and 2 papers in Economics and Econometrics. Recurrent topics in S.B. Vliek's work include BRCA gene mutations in cancer (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Breast Cancer Treatment Studies (2 papers). S.B. Vliek is often cited by papers focused on BRCA gene mutations in cancer (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Breast Cancer Treatment Studies (2 papers). S.B. Vliek collaborates with scholars based in Netherlands, United States and France. S.B. Vliek's co-authors include René J. F. Melis, Marcel G. M. Olde Rikkert, Miriam C. Faes, Marlieke Visser, Paul F. M. Krabbe, Eddy Adang, Claire Wolfs, Valesca P. Retèl, Caroline A. Drukker and Emiel J. Rutgers and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

S.B. Vliek

7 papers receiving 57 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S.B. Vliek Netherlands	4	20	15	15	15	12	7	59
Frederieke H. van der Baan Netherlands	7	8 0.4×	41 2.7×	8 0.5×	3 0.2×	4 0.3×	18	106
Bagas Suryo Bintoro Indonesia	5	4 0.2×	28 1.9×	16 1.1×	2 0.1×	9 0.8×	16	100
Azizah Ab Manan Malaysia	5	4 0.2×	33 2.2×	11 0.7×	3 0.2×	7 0.6×	10	88
Sheila Rutledge Harding Canada	6	9 0.5×	14 0.9×	11 0.7×	4 0.3×	4 0.3×	12	110
Frances McFarland Horne United States	4	9 0.5×	4 0.3×	8 0.5×	16 1.1×	3 0.3×	5	132
Jorge Emerson Chachaima-Mar Peru	5	15 0.8×	3 0.2×	6 0.4×	3 0.2×	5 0.4×	9	48
Michela Libertini Italy	4	5 0.3×	50 3.3×	6 0.4×	2 0.1×	4 0.3×	13	81
Nooreen Alam United Kingdom	6	19 0.9×	21 1.4×	5 0.3×	4 0.3×	3 0.3×	11	94
Antonella Galiano Italy	4	4 0.2×	30 2.0×	5 0.3×	8 0.5×	6 0.5×	15	52
Sanika Rege United States	5	6 0.3×	5 0.3×	5 0.3×	1 0.1×	7 0.6×	19	62

Countries citing papers authored by S.B. Vliek

Since Specialization

Citations

This map shows the geographic impact of S.B. Vliek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.B. Vliek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.B. Vliek more than expected).

Fields of papers citing papers by S.B. Vliek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.B. Vliek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.B. Vliek. The network helps show where S.B. Vliek may publish in the future.

Co-authorship network of co-authors of S.B. Vliek

This figure shows the co-authorship network connecting the top 25 collaborators of S.B. Vliek. A scholar is included among the top collaborators of S.B. Vliek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.B. Vliek. S.B. Vliek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Vliek, S.B., Iris Noordhoek, Elma Meershoek‐Klein Kranenbarg, et al.. (2022). Daily Oral Ibandronate With Adjuvant Endocrine Therapy in Postmenopausal Women With Estrogen Receptor–Positive Breast Cancer (BOOG 2006-04): Randomized Phase III TEAM-IIB Trial. Journal of Clinical Oncology. 40(25). 2934–2945. 8 indexed citations

Vliek, S.B., Florentine Hilbers, Agnes Jager, et al.. (2022). Ten-year follow-up of the observational RASTER study, prospective evaluation of the 70-gene signature in ER-positive, HER2-negative, node-negative, early breast cancer. European Journal of Cancer. 175. 169–179. 4 indexed citations

Vliek, S.B., Agnes Jager, Anthony Gonçalvès, et al.. (2018). Abstract OT2-07-08: Substantially improving the cure rate of high-risk BRCA1-like breast cancer patients with personalized therapy (SUBITO) - an international randomized phase III trial. Cancer Research. 78(4_Supplement). OT2–7. 2 indexed citations

Vliek, S.B., Valesca P. Retèl, Caroline A. Drukker, et al.. (2017). The 70-gene signature in node positive breast cancer: 10-year follow-up of the observational RASTER study. Annals of Oncology. 28. v60–v60. 1 indexed citations

Vliek, S.B., Valesca P. Retèl, Caroline A. Drukker, et al.. (2017). 10 years follow up of the RASTER study; implementing a genomic signature in daily practice. Annals of Oncology. 28. v46–v46. 3 indexed citations

Melis, René J. F., Eddy Adang, Paul F. M. Krabbe, et al.. (2009). Cost-effectiveness of post-diagnosis treatment in dementia coordinated by multidisciplinary memory clinics in comparison to treatment coordinated by general practitioners: An example of a pragmatic trial. The journal of nutrition health & aging. 13(3). 242–248. 27 indexed citations

Vliek, S.B., et al.. (2008). Single versus multicomponent intervention in frail elderly: Simplicity or complexity as precondition for success?. The journal of nutrition health & aging. 12(5). 319–322. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact